Arovella Therapeutics Ltd
ASX:ALA

Watchlist Manager
Arovella Therapeutics Ltd Logo
Arovella Therapeutics Ltd
ASX:ALA
Watchlist
Price: 0.18 AUD -5.26% Market Closed
Market Cap: 189.3m AUD
Have any thoughts about
Arovella Therapeutics Ltd?
Write Note

Arovella Therapeutics Ltd
Gross Profit

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Arovella Therapeutics Ltd
Gross Profit Peer Comparison

Comparables:
MYX
NEU
BOT
PBP
VLS

Competitive Gross Profit Analysis
Latest Figures & CAGR of Competitors

Company Gross Profit CAGR 3Y CAGR 5Y CAGR 10Y
Arovella Therapeutics Ltd
ASX:ALA
Gross Profit
AU$155.7k
CAGR 3-Years
56%
CAGR 5-Years
-32%
CAGR 10-Years
N/A
Mayne Pharma Group Ltd
ASX:MYX
Gross Profit
AU$225.8m
CAGR 3-Years
7%
CAGR 5-Years
-7%
CAGR 10-Years
N/A
Neuren Pharmaceuticals Ltd
ASX:NEU
Gross Profit
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Botanix Pharmaceuticals Ltd
ASX:BOT
Gross Profit
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Probiotec Ltd
ASX:PBP
Gross Profit
AU$66.3m
CAGR 3-Years
28%
CAGR 5-Years
20%
CAGR 10-Years
10%
Vita Life Sciences Ltd
ASX:VLS
Gross Profit
AU$46.2m
CAGR 3-Years
14%
CAGR 5-Years
11%
CAGR 10-Years
6%

See Also

What is Arovella Therapeutics Ltd's Gross Profit?
Gross Profit
155.7k AUD

Based on the financial report for Jun 30, 2024, Arovella Therapeutics Ltd's Gross Profit amounts to 155.7k AUD.

What is Arovella Therapeutics Ltd's Gross Profit growth rate?
Gross Profit CAGR 5Y
-32%

Over the last year, the Gross Profit growth was -33%. The average annual Gross Profit growth rates for Arovella Therapeutics Ltd have been 56% over the past three years , -32% over the past five years .

Back to Top